Sound Pharmaceuticals, Incorporated
12 clinical trials · Sponsor
◉ Watch Sound Pharmaceuticals, Incorporated
| Record | Firm | Date |
|---|---|---|
| SPI-1005 in Adults Receiving Cochlear Implant (NCT06340633) | Sound Pharmaceuticals, Incorporated | 2026-12-01 |
| A Phase 2b Study of SPI-1005 to Prevent Acute Noise Induced Hearing Loss (NCT02779192) | Sound Pharmaceuticals, Incorporated | 2026-06-01 |
| SPI-1005 for Prevention and Treatment of Chemotherapy Induced Hearing Loss (NCT01451853) | Sound Pharmaceuticals, Incorporated | 2026-06-01 |
| SPI-1005 for the Treatment of Meniere's Disease (Open Label) (NCT06859788) | Sound Pharmaceuticals, Incorporated | 2025-10-29 |
| SPI-1005 for the Treatment of Meniere's Disease (NCT04677972) | Sound Pharmaceuticals, Incorporated | 2022-08-02 |
| SPI-1005 Treatment in Moderate COVID-19 Patients (NCT04484025) | Sound Pharmaceuticals, Incorporated | 2021-10-12 |
| SPI-1005 Treatment in Severe COVID-19 Patients (NCT04483973) | Sound Pharmaceuticals, Incorporated | 2021-08-27 |
| SPI-1005 for the Treatment of Patients With Meniere's Disease (NCT03325790) | Sound Pharmaceuticals, Incorporated | 2017-09-28 |
Track Sound Pharmaceuticals, Incorporated automatically
Every clearance here is in the API, with alerts when new ones post.